The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

Pinterest (NYSE: PINS) is still trading up from one year ago by close to 16%, although shares are in the red from the start of 2024. The photo sharing and discovery platform has dealt with fluctuating ...

Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

Baird has recently initiated Vertex Inc (VERX) stock to Outperform rating, as announced on July 23, 2024, according to Finviz. Earlier, on March 1, 2024, BofA Securities had raised the stock from a ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

Vertex, Inc. (NASDAQ: VERX) has launched Vertex for Salesforce Revenue Cloud, an integration designed to streamline revenue ...

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

CRISPR Therapeutics' first therapy is called Casgevy. It treats sickle cell disease (SCD) and beta thalassemia, both rare inherited illnesses that affect the function of a person's red blood cells. It ...

The FDA should have more big news for Vertex only a few weeks later. It expects to announce an approval decision on ...

A portfolio based on the GARP strategy comprises stocks that offer the best value and growth investment. HCA Healthcare, Hubbell, Ferrari and Vertex are some GARP stocks that hold promise.

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...